The impact of properly diagnosed sarcopenia on postoperative outcomes after gastrointestinal surgery: A systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
06
2020
accepted:
31
07
2020
entrez:
22
8
2020
pubmed:
22
8
2020
medline:
21
10
2020
Statut:
epublish
Résumé
Sarcopenia is defined as the loss of muscle mass combined with loss of muscle strength, with or without loss of muscle performance. The use of this parameter as a risk factor for complications after surgery is not currently used. This meta-analysis aims to assess the impact of sarcopenia defined by radiologically and clinically criteria and its relationship with complications after gastrointestinal surgeries. A review of the literature was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (PROSPERO registration number: CRD42019132221). Articles were selected from the PUBMED and EMBASE databases that adequately assessed sarcopenia and its impact on postoperative complications in gastrointestinal surgery patients. Pooled estimates of pre-operative outcome data were calculated using the odds ratio (OR) and 95% confidence interval (CI). Subgroup analysis were performed to assess each type of surgery. The search strategy returned 1323, with 11 studies meeting the inclusion criteria. A total of 4265 patients were analysed. The prevalence of sarcopenia between studies ranged from 6.8% to 35.9%. The meta-analysis showed an OR for complications after surgery of 3.01 (95% CI 2.55-3.55) and an OR of 2.2 (95% CI 1.44-3.36) for hospital readmission (30 days). Sarcopenia, when properly diagnosed, is associated with an increase in late postoperative complications, as well as an increase in the number of postoperative hospital readmissions for various types of gastrointestinal surgery. We believe that any preoperative evaluation should include, in a patient at risk, tests for the diagnosis of sarcopenia and appropriate procedures to reduce its impact on the patient's health.
Sections du résumé
BACKGROUND
Sarcopenia is defined as the loss of muscle mass combined with loss of muscle strength, with or without loss of muscle performance. The use of this parameter as a risk factor for complications after surgery is not currently used. This meta-analysis aims to assess the impact of sarcopenia defined by radiologically and clinically criteria and its relationship with complications after gastrointestinal surgeries.
MATERIALS AND METHODS
A review of the literature was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (PROSPERO registration number: CRD42019132221). Articles were selected from the PUBMED and EMBASE databases that adequately assessed sarcopenia and its impact on postoperative complications in gastrointestinal surgery patients. Pooled estimates of pre-operative outcome data were calculated using the odds ratio (OR) and 95% confidence interval (CI). Subgroup analysis were performed to assess each type of surgery.
RESULTS
The search strategy returned 1323, with 11 studies meeting the inclusion criteria. A total of 4265 patients were analysed. The prevalence of sarcopenia between studies ranged from 6.8% to 35.9%. The meta-analysis showed an OR for complications after surgery of 3.01 (95% CI 2.55-3.55) and an OR of 2.2 (95% CI 1.44-3.36) for hospital readmission (30 days).
CONCLUSION
Sarcopenia, when properly diagnosed, is associated with an increase in late postoperative complications, as well as an increase in the number of postoperative hospital readmissions for various types of gastrointestinal surgery. We believe that any preoperative evaluation should include, in a patient at risk, tests for the diagnosis of sarcopenia and appropriate procedures to reduce its impact on the patient's health.
Identifiants
pubmed: 32822372
doi: 10.1371/journal.pone.0237740
pii: PONE-D-20-18203
pmc: PMC7446889
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0237740Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Gastrointest Surg. 2012 Aug;16(8):1478-86
pubmed: 22692586
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
J Anesth. 2016 Oct;30(5):884-90
pubmed: 27376823
J Gerontol A Biol Sci Med Sci. 2006 Jan;61(1):72-7
pubmed: 16456196
Bull World Health Organ. 2016 Mar 1;94(3):201-209F
pubmed: 26966331
Surgery. 2017 Mar;161(3):680-693
pubmed: 27712873
Ann Surg. 2018 Jul;268(1):58-69
pubmed: 29373365
Gastric Cancer. 2017 Sep;20(5):913-918
pubmed: 28032232
Clin Nutr. 2012 Oct;31(5):652-8
pubmed: 22414775
Adv Nutr. 2015 Jul 15;6(4):452-60
pubmed: 26178029
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
J Gastrointest Surg. 2018 Nov;22(11):1890-1902
pubmed: 29987739
Surgeon. 2019 Dec;17(6):370-380
pubmed: 30389220
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Ann Surg Oncol. 2018 Jun;25(6):1625-1632
pubmed: 29633095
Health Promot Pract. 2020 Jul;21(4):496-498
pubmed: 31874567
J Am Med Dir Assoc. 2013 Jul;14(7):528.e1-7
pubmed: 23664768
Eur J Surg Oncol. 2017 Jan;43(1):188-195
pubmed: 27692536
J Gerontol A Biol Sci Med Sci. 2013 Feb;68(2):168-74
pubmed: 22503991
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006
pubmed: 18923576
Clin Endocrinol (Oxf). 2013 Apr;78(4):525-32
pubmed: 22563924
Gastric Cancer. 2016 Jul;19(3):986-93
pubmed: 26407875
J Clin Densitom. 2015 Oct-Dec;18(4):467-71
pubmed: 26071168
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Ann Surg Oncol. 2018 Feb;25(2):456-464
pubmed: 29214454
Clin Nutr. 2020 Jul;39(7):2301-2310
pubmed: 31732287
J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1199-1204
pubmed: 29300839
Ann R Coll Surg Engl. 2020 Feb;102(2):120-132
pubmed: 31508983
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
Gastric Cancer. 2019 Jan;22(1):10-22
pubmed: 30276574
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Curr Pharm Des. 2008;14(4):405-10
pubmed: 18289066
Cancer Imaging. 2019 Dec 3;19(1):82
pubmed: 31796090
Medicina (Kaunas). 2014;50(2):111-7
pubmed: 25172605
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Liver Transpl. 2019 Oct;25(10):1480-1487
pubmed: 31282126
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
Nutrition. 2019 May;61:61-66
pubmed: 30703570
J Surg Res. 2017 May 1;211:137-146
pubmed: 28501109
Ann Surg Oncol. 2016 Feb;23(2):556-64
pubmed: 26668085
J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:11-6
pubmed: 7493202
J Thorac Dis. 2019 Apr;11(Suppl 5):S645-S653
pubmed: 31080641
J Am Med Dir Assoc. 2013 Mar;14(3):170-8
pubmed: 23276432
Lancet Oncol. 2008 Jul;9(7):629-35
pubmed: 18539529
Dig Dis Sci. 2018 Jun;63(6):1620-1630
pubmed: 29549473
J Cachexia Sarcopenia Muscle. 2012 Dec;3(4):225-37
pubmed: 22648736
PLoS One. 2020 Jun 17;15(6):e0232371
pubmed: 32555707
J Zhejiang Univ Sci B. 2014 Jan;15(1):58-66
pubmed: 24390745
Curr Opin Rheumatol. 2012 Nov;24(6):623-7
pubmed: 22955023
BMC Res Notes. 2011 Apr 14;4:127
pubmed: 21492469
Oncologist. 2016 Nov;21(11):1396-1409
pubmed: 27412391
Pancreatology. 2018 Dec;18(8):996-1004
pubmed: 30287167
Colorectal Dis. 2015 Nov;17(11):O256-64
pubmed: 26194849